{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T20:51:11Z","timestamp":1782161471886,"version":"3.54.5"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>ADAMTS1, a disintegrin and metalloproteinase with thrombospondin motif 1, plays a role in inflammation, organogenesis, and ovulation. Up or downregulation of ADAMTS1 has been implicated in tissue remodelling leading to cancer. We analysed the expression of ADAMTS1 in different stages\/grades of primary and metastatic serous ovarian tumours and ascites-derived tumour cells from patients and assessed the functional role of ADAMTS1 in ovarian cancer (OC) cell lines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The expression and localisation of ADAMTS1 was assessed by immunohistochemistry (IHC) and Opal Multiplex IHC staining\u00a0of OC tissues. Functional roles of ADAMTS1 in OC cell lines\u00a0were assessed by using siRNA-mediated knockdown (KD), MTT assay, cell migration by xCELLigence, cell adhesion, ELISA, qRT-PCR, Western blot, immunofluorescence (IF)\u00a0and activity of Cdc42 GTPase.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The expression of ADAMTS1 was significantly enhanced in higher stages\/grades of ovarian tumours compared to benign tumours. In high-grade tumours, ADAMTS1 was localised more in the nucleus of epithelial cells while localisation in stromal cells was mostly in the cytoplasm. Significantly higher mRNA expression of ADAMTS1 was noted in epithelial compared to mesenchymal ascites-derived tumour cells. The expression of ADAMTS1 was significantly higher in metastatic high-grade tumours compared to primary tumours.<\/jats:p>\n                    <jats:p>KD of ADAMTS1 expression by siRNA in OC cell lines had no effect on cell proliferation but resulted in decreased cell adhesion, increased cell migration accompanied by increased expression of markers (CDH1 and EPCAM) associated with epithelial plasticity. Remodelling of ECM accompanied by increased intra- and extracellular production of VCAN and enhanced Cdc42 GTPase activity was also noted in cell lines with ADAMTS1 KD. Cdc42 GTPase specific inhibitor, ML141, reversed ADAMTS1 KD-mediated enhanced migration. On the other hand, VCAN KD inhibited ADAMTS1 KD-mediated migration and reversed the effect on cell adhesion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These results suggest that the expression of ADAMTS1 progressively enriches ovarian tumours and promotes OC progression. Its knock down in in vitro cell culture impacts ECM remodelling through enhanced Cdc42GTPase activity and VCAN production resulting in epithelial cell plasticity, accelerated migration, and reduced cell adhesion.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12929-026-01260-z","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T18:10:22Z","timestamp":1782151822000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enhanced expression of ADAMTS1 in ovarian carcinomas: loss of ADAMTS1 expression instigates cellular reprogramming of extracellular matrix ensuing altered plasticity, augmented migration and attenuated adhesion"],"prefix":"10.1186","volume":"33","author":[{"given":"Ruth M.","family":"Escalona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noor A.","family":"Lokman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin K.","family":"Oehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Ricciardelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Kannourakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuzhat","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"issue":"3","key":"1260_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"1260_CR2","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s00404-017-4529-z","volume":"296","author":"DM Klotz","year":"2017","unstructured":"Klotz DM, Wimberger P. Cells of origin of ovarian cancer: ovarian surface epithelium or fallopian tube? Arch Gynecol Obstet. 2017;296(6):1055\u201362.","journal-title":"Arch Gynecol Obstet"},{"issue":"10177","key":"1260_CR3","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","volume":"393","author":"S Lheureux","year":"2019","unstructured":"Lheureux S, Gourley C, Vergote I, Oza AM. Epithelial ovarian cancer. Lancet. 2019;393(10177):1240\u201353.","journal-title":"Lancet"},{"issue":"1","key":"1260_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-021-00726-x","volume":"19","author":"T Wesley","year":"2021","unstructured":"Wesley T, Berzins S, Kannourakis G, Ahmed N. The attributes of plakins in cancer and disease: perspectives on ovarian cancer progression, chemoresistance and recurrence. Cell Commun Signal. 2021;19(1):55.","journal-title":"Cell Commun Signal"},{"key":"1260_CR5","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3389\/fonc.2013.00256","volume":"3","author":"N Ahmed","year":"2013","unstructured":"Ahmed N, Stenvers KL. Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research. Front Oncol. 2013;3:256.","journal-title":"Front Oncol"},{"issue":"3","key":"1260_CR6","doi-asserted-by":"publisher","DOI":"10.1063\/1.5024386","volume":"2","author":"C Novak","year":"2018","unstructured":"Novak C, Horst E, Mehta G. Review: mechanotransduction in ovarian cancer: shearing into the unknown. APL Bioeng. 2018;2(3):031701.","journal-title":"APL Bioeng"},{"issue":"3","key":"1260_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0194170","volume":"13","author":"AR Hyler","year":"2018","unstructured":"Hyler AR, Baudoin NC, Brown MS, Stremler MA, Cimini D, Davalos RV, et al. Fluid shear stress impacts ovarian cancer cell viability, subcellular organization, and promotes genomic instability. PLoS ONE. 2018;13(3):e0194170.","journal-title":"PLoS ONE"},{"issue":"1","key":"1260_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.112397","volume":"399","author":"SLE Compton","year":"2021","unstructured":"Compton SLE, Pyne ES, Liu L, Guinan J, Shea AA, Grieco JP, et al. Adaptation of metabolism to multicellular aggregation, hypoxia and obese stromal cell incorporation as potential measure of survival of ovarian metastases. Exp Cell Res. 2021;399(1):112397.","journal-title":"Exp Cell Res"},{"key":"1260_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217022","volume":"596","author":"Y Yu","year":"2024","unstructured":"Yu Y, Lyu C, Li X, Yang L, Wang J, Li H, et al. Remodeling of tumor microenvironment by extracellular matrix protein 1a differentially regulates ovarian cancer metastasis. Cancer Lett. 2024;596:217022.","journal-title":"Cancer Lett"},{"issue":"1","key":"1260_CR10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.54457\/DR.202401004","volume":"4","author":"R Bacchetti","year":"2024","unstructured":"Bacchetti R, Yuan S, Rainero E. ADAMTS proteases: Their multifaceted role in the regulation of cancer metastasis. Dis Res. 2024;4(1):40\u201352.","journal-title":"Dis Res"},{"issue":"10","key":"1260_CR11","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1002\/ijc.28127","volume":"133","author":"IA Tan","year":"2013","unstructured":"Tan IA, Ricciardelli C, Russell DL. The metalloproteinase ADAMTS1: a comprehensive review of its role in tumorigenic and metastatic pathways. Int J Cancer. 2013;133(10):2263\u201376.","journal-title":"Int J Cancer"},{"key":"1260_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.matbio.2015.05.004","volume":"47","author":"D Hubmacher","year":"2015","unstructured":"Hubmacher D, Apte SS. ADAMTS proteins as modulators of microfibril formation and function. Matrix Biol. 2015;47:34\u201343.","journal-title":"Matrix Biol"},{"issue":"1","key":"1260_CR13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13059-015-0676-3","volume":"16","author":"R Kelwick","year":"2015","unstructured":"Kelwick R, Desanlis I, Wheeler GN, Edwards DR. The ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family. Genome Biol. 2015;16(1):113.","journal-title":"Genome Biol"},{"issue":"2","key":"1260_CR14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10585-010-9363-7","volume":"28","author":"MP Ween","year":"2011","unstructured":"Ween MP, Hummitzsch K, Rodgers RJ, Oehler MK, Ricciardelli C. Versican induces a pro-metastatic ovarian cancer cell behavior which can be inhibited by small hyaluronan oligosaccharides. Clin Exp Metastasis. 2011;28(2):113\u201325.","journal-title":"Clin Exp Metastasis"},{"key":"1260_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1757-2215-7-70","volume":"7","author":"M Desjardins","year":"2014","unstructured":"Desjardins M, Xie J, Gurler H, Muralidhar GG, Sacks JD, Burdette JE, et al. Versican regulates metastasis of epithelial ovarian carcinoma cells and spheroids. J Ovarian Res. 2014;7:70.","journal-title":"J Ovarian Res"},{"issue":"14","key":"1260_CR16","doi-asserted-by":"publisher","first-page":"10814","DOI":"10.1074\/jbc.M606991200","volume":"282","author":"C Ricciardelli","year":"2007","unstructured":"Ricciardelli C, Russell DL, Ween MP, Mayne K, Suwiwat S, Byers S, et al. Formation of hyaluronan- and versican-rich pericellular matrix by prostate cancer cells promotes cell motility. J Biol Chem. 2007;282(14):10814\u201325.","journal-title":"J Biol Chem"},{"key":"1260_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215779","volume":"543","author":"A Russo","year":"2022","unstructured":"Russo A, Yang Z, Heyrman GM, Cain BP, Lopez Carrero A, Isenberg BC, et al. Versican secreted by the ovary links ovulation and migration in fallopian tube derived serous cancer. Cancer Lett. 2022;543:215779.","journal-title":"Cancer Lett"},{"issue":"4","key":"1260_CR18","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.biocel.2008.08.014","volume":"41","author":"JC Rodriguez-Manzaneque","year":"2009","unstructured":"Rodriguez-Manzaneque JC, Carpizo D, Plaza-Calonge MC, Torres-Collado AX, Thai SN, Simons M, et al. Cleavage of syndecan-4 by ADAMTS1 provokes defects in adhesion. Int J Biochem Cell Biol. 2009;41(4):800\u201310.","journal-title":"Int J Biochem Cell Biol"},{"issue":"Pt 17","key":"1260_CR19","first-page":"3799","volume":"126","author":"A Elfenbein","year":"2013","unstructured":"Elfenbein A, Simons M. Syndecan-4 signaling at a glance. J Cell Sci. 2013;126(Pt 17):3799\u2013804.","journal-title":"J Cell Sci"},{"key":"1260_CR20","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.235762","author":"J Lambert","year":"2020","unstructured":"Lambert J, Makin K, Akbareian S, Johnson R, Alghamdi AAA, Robinson SD, et al. ADAMTS-1 and syndecan-4 intersect in the regulation of cell migration and angiogenesis. J Cell Sci. 2020. https:\/\/doi.org\/10.1242\/jcs.235762.","journal-title":"J Cell Sci"},{"issue":"2","key":"1260_CR21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.cancergencyto.2008.08.001","volume":"187","author":"JE Choi","year":"2008","unstructured":"Choi JE, Kim DS, Kim EJ, Chae MH, Cha SI, Kim CH, et al. Aberrant methylation of ADAMTS1 in non-small cell lung cancer. Cancer Genet Cytogenet. 2008;187(2):80\u20134.","journal-title":"Cancer Genet Cytogenet"},{"key":"1260_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-12-2","volume":"12","author":"VM Freitas","year":"2013","unstructured":"Freitas VM, do Amaral JB, Silva TA, Santos ES, Mangone FR, Pinheiro JJ, et al. Decreased expression of ADAMTS-1 in human breast tumors stimulates migration and invasion. Mol Cancer. 2013;12:2.","journal-title":"Mol Cancer"},{"issue":"1","key":"1260_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s10147-022-02268-9","volume":"28","author":"S Wang","year":"2023","unstructured":"Wang S, Zhang J, Wang K, Zhao Y, Liu D. ADAMTS1 as potential prognostic biomarker promotes malignant invasion of glioma. Int J Clin Oncol. 2023;28(1):52\u201368.","journal-title":"Int J Clin Oncol"},{"issue":"6","key":"1260_CR24","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1159\/000446244","volume":"83","author":"MA Lima","year":"2016","unstructured":"Lima MA, Dos Santos L, Turri JA, Nonogaki S, Buim M, Lima JF, et al. Prognostic value of ADAMTS proteases and their substrates in epithelial ovarian cancer. Pathobiology. 2016;83(6):316\u201326.","journal-title":"Pathobiology"},{"issue":"6","key":"1260_CR25","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1002\/hep.24598","volume":"54","author":"K Bourd-Boittin","year":"2011","unstructured":"Bourd-Boittin K, Bonnier D, Leyme A, Mari B, Tuffery P, Samson M, et al. Protease profiling of liver fibrosis reveals the ADAM metallopeptidase with thrombospondin type 1 motif, 1 as a central activator of transforming growth factor beta. Hepatology. 2011;54(6):2173\u201384.","journal-title":"Hepatology"},{"issue":"41","key":"1260_CR26","doi-asserted-by":"publisher","first-page":"34796","DOI":"10.1074\/jbc.M506980200","volume":"280","author":"NV Lee","year":"2005","unstructured":"Lee NV, Rodriguez-Manzaneque JC, Thai SN, Twal WO, Luque A, Lyons KM, et al. Fibulin-1 acts as a cofactor for the matrix metalloprotease ADAMTS-1. J Biol Chem. 2005;280(41):34796\u2013804.","journal-title":"J Biol Chem"},{"issue":"17","key":"1260_CR27","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1038\/sj.onc.1209287","volume":"25","author":"YJ Liu","year":"2006","unstructured":"Liu YJ, Xu Y, Yu Q. Full-length ADAMTS-1 and the ADAMTS-1 fragments display pro- and antimetastatic activity, respectively. Oncogene. 2006;25(17):2452\u201367.","journal-title":"Oncogene"},{"issue":"6","key":"1260_CR28","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.18632\/aging.204594","volume":"15","author":"X Hu","year":"2023","unstructured":"Hu X, Jiang C, Hu N, Hong S. ADAMTS1 induces epithelial-mesenchymal transition pathway in non-small cell lung cancer by regulating TGF-beta. Aging. 2023;15(6):2097\u2013114.","journal-title":"Aging"},{"issue":"1","key":"1260_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06452-9","volume":"15","author":"MH Chien","year":"2024","unstructured":"Chien MH, Yang YC, Ho KH, Ding YF, Chen LH, Chiu WK, et al. Cyclic increase in the ADAMTS1-L1CAM-EGFR axis promotes the EMT and cervical lymph node metastasis of oral squamous cell carcinoma. Cell Death Dis. 2024;15(1):82.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1260_CR30","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s11658-024-00643-0","volume":"29","author":"YC Wen","year":"2024","unstructured":"Wen YC, Lin YW, Ho KH, Yang YC, Lai FR, Chu CY, et al. The oncogenic ADAMTS1-VCAN-EGFR cyclic axis drives anoikis resistance and invasion in renal cell carcinoma. Cell Mol Biol Lett. 2024;29(1):126.","journal-title":"Cell Mol Biol Lett"},{"key":"1260_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2020.109827","volume":"77","author":"M de Assis Lima","year":"2021","unstructured":"de Assis Lima M, da Silva SV, Serrano-Garrido O, Hulsemann M, Santos-Neres L, Rodriguez-Manzaneque JC, et al. Metalloprotease ADAMTS-1 decreases cell migration and invasion modulating the spatiotemporal dynamics of Cdc42 activity. Cell Signal. 2021;77:109827.","journal-title":"Cell Signal"},{"key":"1260_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/cells14090655","author":"A Raza","year":"2025","unstructured":"Raza A, Hoque A, Luwor R, Escalona RM, Kelly J, Sharma R, et al. Enhanced expression of mitochondrial Magmas protein in ovarian carcinomas: Magmas inhibition facilitates antitumour effects, signifying a novel approach for ovarian cancer treatment. Cells. 2025. https:\/\/doi.org\/10.3390\/cells14090655.","journal-title":"Cells"},{"issue":"1","key":"1260_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07274-6","volume":"20","author":"RM Escalona","year":"2020","unstructured":"Escalona RM, Bilandzic M, Western P, Kadife E, Kannourakis G, Findlay JK, et al. TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells. BMC Cancer. 2020;20(1):960.","journal-title":"BMC Cancer"},{"issue":"1","key":"1260_CR34","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1186\/s12935-022-02838-x","volume":"22","author":"RM Escalona","year":"2022","unstructured":"Escalona RM, Chu S, Kadife E, Kelly JK, Kannourakis G, Findlay JK, et al. Knock down of TIMP-2 by siRNA and CRISPR\/Cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer. Cancer Cell Int. 2022;22(1):422.","journal-title":"Cancer Cell Int"},{"key":"1260_CR35","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.trsl.2016.02.002","volume":"171","author":"NA Lokman","year":"2016","unstructured":"Lokman NA, Pyragius CE, Ruszkiewicz A, Oehler MK, Ricciardelli C. Annexin A2 and S100A10 are independent predictors of serous ovarian cancer outcome. Transl Res. 2016;171:83\u201395 (e81-82).","journal-title":"Transl Res"},{"issue":"1","key":"1260_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fernandez JA, Dombrowski Y, McArt DG, Dunne PD, et al. QuPath: open source software for digital pathology image analysis. Sci Rep. 2017;7(1):16878.","journal-title":"Sci Rep"},{"issue":"10","key":"1260_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046858","volume":"7","author":"A Latifi","year":"2012","unstructured":"Latifi A, Luwor RB, Bilandzic M, Nazaretian S, Stenvers K, Pyman J, et al. Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors. PLoS ONE. 2012;7(10):e46858.","journal-title":"PLoS ONE"},{"key":"1260_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.796588","volume":"11","author":"RM Escalona","year":"2021","unstructured":"Escalona RM, Kannourakis G, Findlay JK, Ahmed N. Expression of TIMPs and MMPs in ovarian tumors, ascites, ascites-derived cells, and cancer cell lines: characteristic modulatory response before and after chemotherapy treatment. Front Oncol. 2021;11:796588.","journal-title":"Front Oncol"},{"issue":"6220","key":"1260_CR39","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhlen","year":"2015","unstructured":"Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347(6220):1260419.","journal-title":"Science"},{"issue":"Suppl 5","key":"1260_CR40","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12920-019-0514-7","volume":"12","author":"SJ Park","year":"2019","unstructured":"Park SJ, Yoon BH, Kim SK, Kim SY. GENT2: an updated gene expression database for normal and tumor tissues. BMC Med Genomics. 2019;12(Suppl 5):101.","journal-title":"BMC Med Genomics"},{"issue":"11","key":"1260_CR41","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s00018-023-04972-9","volume":"80","author":"ZK Price","year":"2023","unstructured":"Price ZK, Lokman NA, Sugiyama M, Koya Y, Yoshihara M, Oehler MK, et al. Disabled-2: a protein up-regulated by high molecular weight hyaluronan has both tumor promoting and tumor suppressor roles in ovarian cancer. Cell Mol Life Sci. 2023;80(11):320.","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"1260_CR42","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1007\/s11357-023-00742-4","volume":"45","author":"B Gyorffy","year":"2023","unstructured":"Gyorffy B. Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer. Geroscience. 2023;45(3):1889\u201398.","journal-title":"Geroscience"},{"issue":"3","key":"1260_CR43","volume":"5","author":"B Gyorffy","year":"2024","unstructured":"Gyorffy B. Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors. Innovation. 2024;5(3):100625.","journal-title":"Innovation"},{"issue":"17","key":"1260_CR44","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw578","volume":"44","author":"JK Blayney","year":"2016","unstructured":"Blayney JK, Davison T, McCabe N, Walker S, Keating K, Delaney T, et al. Prior knowledge transfer across transcriptional data sets and technologies using compositional statistics yields new mislabelled ovarian cell line. Nucleic Acids Res. 2016;44(17):e137.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"1260_CR45","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1158\/1535-7163.MCT-08-0921","volume":"8","author":"PL Lorenzi","year":"2009","unstructured":"Lorenzi PL, Reinhold WC, Varma S, Hutchinson AA, Pommier Y, Chanock SJ, et al. DNA fingerprinting of the NCI-60 cell line panel. Mol Cancer Ther. 2009;8(4):713\u201324.","journal-title":"Mol Cancer Ther"},{"issue":"10","key":"1260_CR46","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1136\/jclinpath-2014-202430","volume":"67","author":"AL Kwok","year":"2014","unstructured":"Kwok AL, Wong OG, Wong ES, Tsun OK, Chan KK, Cheung AN. Caution over use of ES2 as a model of ovarian clear cell carcinoma. J Clin Pathol. 2014;67(10):921\u20132.","journal-title":"J Clin Pathol"},{"issue":"5","key":"1260_CR47","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1369\/00221554211007793","volume":"69","author":"M Willemsen","year":"2021","unstructured":"Willemsen M, Krebbers G, Bekkenk MW, Teunissen MBM, Luiten RM. Improvement of Opal multiplex immunofluorescence workflow for human tissue sections. J Histochem Cytochem. 2021;69(5):339\u201346.","journal-title":"J Histochem Cytochem"},{"key":"1260_CR48","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1477-3163-6-11","volume":"6","author":"K Shield","year":"2007","unstructured":"Shield K, Riley C, Quinn MA, Rice GE, Ackland ML, Ahmed N. Alpha2beta1 integrin affects metastatic potential of ovarian carcinoma spheroids by supporting disaggregation and proteolysis. J Carcinog. 2007;6:11.","journal-title":"J Carcinog"},{"issue":"10","key":"1260_CR49","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/j.yexcr.2013.03.016","volume":"319","author":"S Schlie-Wolter","year":"2013","unstructured":"Schlie-Wolter S, Ngezahayo A, Chichkov BN. The selective role of ECM components on cell adhesion, morphology, proliferation and communication in vitro. Exp Cell Res. 2013;319(10):1553\u201361.","journal-title":"Exp Cell Res"},{"issue":"1","key":"1260_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54920-9","volume":"15","author":"CJ Lee","year":"2024","unstructured":"Lee CJ, Jang TY, Jeon SE, Yun HJ, Cho YH, Lim DY, et al. The dysadherin\/MMP9 axis modifies the extracellular matrix to accelerate colorectal cancer progression. Nat Commun. 2024;15(1):10422.","journal-title":"Nat Commun"},{"issue":"1","key":"1260_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18794-x","volume":"11","author":"J Winkler","year":"2020","unstructured":"Winkler J, Abisoye-Ogunniyan A, Metcalf KJ, Werb Z. Concepts of extracellular matrix remodelling in tumour progression and metastasis. Nat Commun. 2020;11(1):5120.","journal-title":"Nat Commun"},{"key":"1260_CR52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cytogfr.2025.05.004","volume":"85","author":"W Luo","year":"2025","unstructured":"Luo W, Shi Q, Han M, Zhang Z, Reiter RJ, Ashrafizadeh M, et al. TGF-beta-driven EMT in cancer progression and drug resistance. Cytokine Growth Factor Rev. 2025;85:11\u201325.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"11","key":"1260_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049766","volume":"7","author":"A Misra","year":"2012","unstructured":"Misra A, Pandey C, Sze SK, Thanabalu T. Hypoxia activated EGFR signaling induces epithelial to mesenchymal transition (EMT). PLoS ONE. 2012;7(11):e49766.","journal-title":"PLoS ONE"},{"issue":"5","key":"1260_CR54","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1593\/neo.04241","volume":"6","author":"L Xie","year":"2004","unstructured":"Xie L, Law BK, Chytil AM, Brown KA, Aakre ME, Moses HL. Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro. Neoplasia. 2004;6(5):603\u201310.","journal-title":"Neoplasia"},{"issue":"1","key":"1260_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01646-1","volume":"21","author":"H Schinke","year":"2022","unstructured":"Schinke H, Shi E, Lin Z, Quadt T, Kranz G, Zhou J, et al. A transcriptomic map of EGFR-induced epithelial-to-mesenchymal transition identifies prognostic and therapeutic targets for head and neck cancer. Mol Cancer. 2022;21(1):178.","journal-title":"Mol Cancer"},{"key":"1260_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00796","volume":"9","author":"T Fontanil","year":"2019","unstructured":"Fontanil T, Mohamedi Y, Cobo T, Cal S, Obaya AJ. Novel associations within the tumor microenvironment: fibulins meet ADAMTSs. Front Oncol. 2019;9:796.","journal-title":"Front Oncol"},{"key":"1260_CR57","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.matbio.2014.01.005","volume":"35","author":"S Nandadasa","year":"2014","unstructured":"Nandadasa S, Foulcer S, Apte SS. The multiple, complex roles of versican and its proteolytic turnover by ADAMTS proteases during embryogenesis. Matrix Biol. 2014;35:34\u201341.","journal-title":"Matrix Biol"},{"issue":"1","key":"1260_CR58","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ygyno.2010.05.029","volume":"119","author":"S Ghosh","year":"2010","unstructured":"Ghosh S, Albitar L, LeBaron R, Welch WR, Samimi G, Birrer MJ, et al. Up-regulation of stromal versican expression in advanced stage serous ovarian cancer. Gynecol Oncol. 2010;119(1):114\u201320.","journal-title":"Gynecol Oncol"},{"issue":"11","key":"1260_CR59","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1517\/14728222.2013.828037","volume":"17","author":"LE Arias-Romero","year":"2013","unstructured":"Arias-Romero LE, Chernoff J. Targeting Cdc42 in cancer. Expert Opin Ther Targets. 2013;17(11):1263\u201373.","journal-title":"Expert Opin Ther Targets"},{"key":"1260_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2025.114724","volume":"253","author":"X Li","year":"2025","unstructured":"Li X, Tan C, Fu X, Qiu J, Shen W, Xu Z, et al. Disrupting Cdc42 activation-driven filopodia formation with low-intensity ultrasound and microbubbles: a novel strategy to block ovarian cancer metastasis. Colloids Surf B Biointerfaces. 2025;253:114724.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"6","key":"1260_CR61","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1016\/j.ajpath.2011.08.021","volume":"179","author":"C Ricciardelli","year":"2011","unstructured":"Ricciardelli C, Frewin KM, Tan IA, Williams ED, Opeskin K, Pritchard MA, et al. The ADAMTS1 protease gene is required for mammary tumor growth and metastasis. Am J Pathol. 2011;179(6):3075\u201385.","journal-title":"Am J Pathol"},{"issue":"43","key":"1260_CR62","doi-asserted-by":"publisher","first-page":"42330","DOI":"10.1074\/jbc.M300519200","volume":"278","author":"DL Russell","year":"2003","unstructured":"Russell DL, Doyle KM, Ochsner SA, Sandy JD, Richards JS. Processing and localization of ADAMTS-1 and proteolytic cleavage of versican during cumulus matrix expansion and ovulation. J Biol Chem. 2003;278(43):42330\u20139.","journal-title":"J Biol Chem"},{"issue":"10","key":"1260_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0165061","volume":"11","author":"SV Silva","year":"2016","unstructured":"Silva SV, Lima MA, Cella N, Jaeger RG, Freitas VM. ADAMTS-1 is found in the nuclei of normal and tumoral breast cells. PLoS ONE. 2016;11(10):e0165061.","journal-title":"PLoS ONE"},{"issue":"2","key":"1260_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2023.113852","volume":"433","author":"SV Silva","year":"2023","unstructured":"Silva SV, Lima MA, Hodgson L, Freitas VM, Rodriguez-Manzaneque JC. ADAMTS-1 has nuclear localization in cells with epithelial origin and leads to decreased cell migration. Exp Cell Res. 2023;433(2):113852.","journal-title":"Exp Cell Res"},{"issue":"6","key":"1260_CR65","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.carpath.2015.07.010","volume":"24","author":"JM Carthy","year":"2015","unstructured":"Carthy JM, Abraham T, Meredith AJ, Boroomand S, McManus BM. Versican localizes to the nucleus in proliferating mesenchymal cells. Cardiovasc Pathol. 2015;24(6):368\u201374.","journal-title":"Cardiovasc Pathol"},{"key":"1260_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00522","volume":"8","author":"K Harikrishnan","year":"2020","unstructured":"Harikrishnan K, Joshi O, Madangirikar S, Balasubramanian N. Cell derived matrix fibulin-1 associates with epidermal growth factor receptor to inhibit its activation, localization and function in lung cancer Calu-1 cells. Front Cell Dev Biol. 2020;8:522.","journal-title":"Front Cell Dev Biol"},{"issue":"Pt 24","key":"1260_CR67","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.1242\/jcs.114.24.4587","volume":"114","author":"WO Twal","year":"2001","unstructured":"Twal WO, Czirok A, Hegedus B, Knaak C, Chintalapudi MR, Okagawa H, et al. Fibulin-1 suppression of fibronectin-regulated cell adhesion and motility. J Cell Sci. 2001;114(Pt 24):4587\u201398.","journal-title":"J Cell Sci"},{"issue":"4","key":"1260_CR68","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.devcel.2008.03.003","volume":"14","author":"AJ Ewald","year":"2008","unstructured":"Ewald AJ, Brenot A, Duong M, Chan BS, Werb Z. Collective epithelial migration and cell rearrangements drive mammary branching morphogenesis. Dev Cell. 2008;14(4):570\u201381.","journal-title":"Dev Cell"},{"issue":"7","key":"1260_CR69","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrm2720","volume":"10","author":"P Friedl","year":"2009","unstructured":"Friedl P, Gilmour D. Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol. 2009;10(7):445\u201357.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1260_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.704939","volume":"9","author":"P Lu","year":"2021","unstructured":"Lu P, Lu Y. Born to run? Diverse modes of epithelial migration. Front Cell Dev Biol. 2021;9:704939.","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"1260_CR71","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1091\/mbc.e05-10-0951","volume":"17","author":"W Sheng","year":"2006","unstructured":"Sheng W, Wang G, La Pierre DP, Wen J, Deng Z, Wong CK, et al. Versican mediates mesenchymal-epithelial transition. Mol Biol Cell. 2006;17(4):2009\u201320.","journal-title":"Mol Biol Cell"},{"issue":"23","key":"1260_CR72","doi-asserted-by":"publisher","first-page":"34507","DOI":"10.18632\/oncotarget.8922","volume":"7","author":"R Fernandez-Rodriguez","year":"2016","unstructured":"Fernandez-Rodriguez R, Rodriguez-Baena FJ, Martino-Echarri E, Peris-Torres C, Plaza-Calonge MDC, Rodriguez-Manzaneque JC. Stroma-derived but not tumor ADAMTS1 is a main driver of tumor growth and metastasis. Oncotarget. 2016;7(23):34507\u201319.","journal-title":"Oncotarget"},{"issue":"1","key":"1260_CR73","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2025.2508057","volume":"14","author":"R Caracuel-Peramos","year":"2025","unstructured":"Caracuel-Peramos R, Rodriguez-Baena FJ, Redondo-Garcia S, Villatoro-Garcia JA, Garcia-Munoz A, Peris-Torres C, et al. Loss of the extracellular protease ADAMTS1 reveals an antitumorigenic program involving the action of NIDOGEN-1 on macrophage polarization. Oncoimmunology. 2025;14(1):2508057.","journal-title":"Oncoimmunology"},{"issue":"6","key":"1260_CR74","first-page":"1553","volume":"52","author":"IA Tan","year":"2019","unstructured":"Tan IA, Frewin K, Ricciardelli C, Russell DL. ADAMTS1 promotes adhesion to extracellular matrix proteins and predicts prognosis in early stage breast cancer patients. Cell Physiol Biochem. 2019;52(6):1553\u201368.","journal-title":"Cell Physiol Biochem"},{"issue":"22","key":"1260_CR75","doi-asserted-by":"publisher","first-page":"9541","DOI":"10.1158\/0008-5472.CAN-08-0548","volume":"68","author":"N Rocks","year":"2008","unstructured":"Rocks N, Paulissen G, Quesada-Calvo F, Munaut C, Gonzalez ML, Gueders M, et al. ADAMTS-1 metalloproteinase promotes tumor development through the induction of a stromal reaction in vivo. Cancer Res. 2008;68(22):9541\u201350.","journal-title":"Cancer Res"},{"issue":"9","key":"1260_CR76","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.cellsig.2011.04.001","volume":"23","author":"K Stengel","year":"2011","unstructured":"Stengel K, Zheng Y. Cdc42 in oncogenic transformation, invasion, and tumorigenesis. Cell Signal. 2011;23(9):1415\u201323.","journal-title":"Cell Signal"},{"issue":"6","key":"1260_CR77","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1083\/jcb.200403043","volume":"167","author":"YS Chu","year":"2004","unstructured":"Chu YS, Thomas WA, Eder O, Pincet F, Perez E, Thiery JP, et al. Force measurements in E-cadherin-mediated cell doublets reveal rapid adhesion strengthened by actin cytoskeleton remodeling through Rac and Cdc42. J Cell Biol. 2004;167(6):1183\u201394.","journal-title":"J Cell Biol"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-026-01260-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12929-026-01260-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-026-01260-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T20:02:40Z","timestamp":1782158560000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12929-026-01260-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1260"],"URL":"https:\/\/doi.org\/10.1186\/s12929-026-01260-z","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"5 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Research and Ethics Committee of Royal Women\u2019s Hospital (Ethics approval #09\/09), Melbourne, Australia and Human Ethics Committee of Royal Adelaide Hospital (RAH protocols#060,903 and 140, 201), Adelaide, Australia. Human ovarian tumour samples were acquired from patients after obtaining written patient information consent as indicated in the respective Ethics Approvals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have seen the contents in the manuscript and agree for its publication. The authors also agree with the order of authorship in the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"67"}}